1. Journal of Renal Nutrition
One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis 
Jessica Kendrick, MD, MPH, Vidhya Parameswaran, MPH, Linda H. Ficociello, DSc, Norma J. Ofsthun, PhD, Shannon Davis, RD, Claudy Mullon, PhD, Robert J. Kossmann, MD, FACP, FASN, Kamyar Kalantar-Zadeh, MD, MPH, PhD 
Journal of Renal Nutrition 
DOI: /j.jrn
Copyright © 2018 The Authors Terms and Conditions

2. Figure 1
Monthly distribution of patients stratified by serum phosphorus levels. PB, phosphate binder; SO, sucroferric oxyhydroxide; sP, serum phosphorus concentration.
Journal of Renal Nutrition DOI: ( /j.jrn )
Copyright © 2018 The Authors Terms and Conditions

3. Figure 2
Percentage of patients achieving serum phosphorus ≤5.5 mg/dL stratified by baseline phosphate binder type. Figure does not include 25 patients who switched between sevelamer, calcium acetate, and/or lanthanum carbonate at baseline and those on magnesium carbonate. CaAc, calcium acetate; LC, lanthanum carbonate; Sev, sevelamer; SO, sucroferric oxyhydroxide.
Journal of Renal Nutrition DOI: ( /j.jrn )
Copyright © 2018 The Authors Terms and Conditions